ArticleJournal of robotic surgery2026
Predicting extraperitoneal ssRARP difficulty: an MRI-based nomogram.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LASSO-based nomogram and machine learning models for predicting 30-day nasogastric tube dependence after acute ischemic stroke.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To develop and validate an MRI-clinical nomogram predicting surgical difficulty in extraperitoneal single-site robot-assisted radical prostatectomy (ssRARP). We retrospectively evaluated 252 patients undergoing extraperitoneal ssRARP. High difficulty was defined using cohort-specific ≥ 75th percentiles for console time (≥ 107.75 min) or estimated blood loss (≥ 50 mL). A nomogram was constructed via multivariable logistic regression and assessed using AUC, calibration plots, bootstrap validation, and decision curve analysis (DCA). High difficulty occurred in 124 patients (49.2%). Independent predictors included higher body mass index (OR = 1.122, P = 0.012), neoadjuvant therapy (OR = 1.972, P = 0.019), larger prostate volume (OR = 1.020, P = 0.003), narrower intertuberous distance (OR = 0.971, P = 0.043), and greater symphysis pubis height (OR = 1.071, P = 0.017). The nomogram showed acceptable discrimination (AUC = 0.675; optimism-corrected C-index = 0.650), good calibration, and positive DCA net benefit (13-92% thresholds). This novel nomogram optimizes patient selection and mitigates perioperative risks. However, because the difficulty thresholds were calibrated to our institution's specific cohort, recalibration is required before direct application to other centers.
Indexed as
Identifiers
42319727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.